MetaCap

Black Hawk Acquisition Corporation Class A (BKHA)

NASDAQ: BKHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.85-4.63 (-71.45%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BKHA stock chart

Technical analysis

Key statistics

All statistics
52-week range
1.75 – 23.00
Day range
1.75 – 2.39
Volume / Avg
2.13M / 101.40K
Beta
—

52-week range

$1.75$23.00

BKHA stock today

On Nov 20, BKHA ended the session at $1.85, shedding $4.63 (71.45%), versus the S&P 500's 3.70% decline. Volume was 21.0x the average at 2.13M shares, a sign of unusually heavy trading. At this level, BKHA sits near the bottom of its 52-week range of $1.75 to $23.00: 92.0% below the high, set on Oct 12, 2026 and 5.7% above the low.

Black Hawk Acquisition trades at 5.6x its trailing twelve-month earnings per share of $0.33.

Summary generated from market data by MetaCap's automated system. Methodology

About Black Hawk Acquisition

Company profile

Black Hawk Acquisition Corporation is a blank check company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in Danville, California.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Mr. Kent Louis Kaufman
Headquarters
Danville, CA
IPO year
2024
Website
bhspac.com

Financial highlights

Full financials

Net income was $1.3 million (-30.6% year over year).

Black Hawk Acquisition annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024
Revenue——
Growth——
Net income$1.33M$1.92M
EPS (diluted)——

Black Hawk Acquisition peers

Health Care sector
BKHA peer companies
CompanyPrice% ChgMarket capCompare
ALGSAligos Therapeutics Inc.1.22-2.40%$7.62Mvs BKHA
INTSIntensity Therapeutics Inc.2.48-2.36%$8.19Mvs BKHA
INABIN8bio Inc.0.758-1.86%$8.19Mvs BKHA
JSPRJasper Therapeutics Inc.8.69-18.25%$9.64Mvs BKHA
ATYRaTyr Pharma Inc.3.82+3.52%$9.74Mvs BKHA
TCRXTScan Therapeutics Inc.0.1459+2.24%$9.89Mvs BKHA
VIVSVivoSim Labs Inc.0.2608-10.53%$5.29Mvs BKHA
SNTISenti Biosciences Holdings Inc.1.77-36.56%$4.60Mvs BKHA

Indexes, lists and sector

Black Hawk Acquisition stock FAQ

What is Black Hawk Acquisition's stock price today?

BKHA last traded at $1.85 as of Nov 20, 4:00 PM EST, down 71.45% on the day. Prices are delayed at least 15 minutes.

What is BKHA's P/E ratio?

BKHA trades at a trailing P/E ratio of 5.61.

Who is Black Hawk Acquisition's CEO?

Mr. Kent Louis Kaufman is the chief executive officer of Black Hawk Acquisition Corporation Class A.

What is the BKHA 52-week high?

The 52-week high for BKHA is $23.00 and the 52-week low is $1.75. The stock is currently 92.0% below its high.

Compare BKHA